Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics.

The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and Systemic oral delivery platform for oral delivery of large molecules for management of chronic diseases.

The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline.

Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.